drugset / Trial / NCT00004443

Study of NTBC for Tyrosinemia I

NCT00004443

Completed 20 enrolled University of Washington
Treatment

Summary

OBJECTIVES: I. Assess the safety and efficacy of NTBC in children with tyrosinemia I. II. Evaluate the effects of NTBC on survival, rate of neurologic crises, improvement in renal tubular damage, reduction in the need for liver transplantation, and reduction in the development of hepatocarcinoma in these patients.

Timeline

Start
1998-10
Primary completion
Completion
2006-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitisinone Small molecule Oral

Indications